Aoocrding to the first article, some of the supposed cheaters maye have really f---ed themselves up.
And according to the second, SOME others may not be getting their money's worth.
FIRST DOW JONES NEW ARTICLE
09/23 4:18P
J&J Declines To Shed More Light On Eprex Health Risks
By Hollister H. Hovey
Of DOW JONES NEWSWIRES
NEW YORK (Dow Jones)--Johnson & Johnson (JNJ) officials wouldn't further
address the problems associated with its anemia drug Eprex ?
In a handful of cases, Eprex, the international name for a drug Johnson &
Johnson calls Procrit in the U.S., has actually exacerbated kidney-disease
patients' anemia rather than cure it.
Eprex has been linked to 141 cases of pure red blood cell aplasia, which
leaves patients with antibodies that block their bodies from making red blood
cells. To survive, these patients now must depend on transfusions or
immunosuppressive drugs.
The cases started to appear in 1999, shortly after Johnson & Johnson changed
the manufacturing practices at a Puerto Rican plant that makes the drug.
[?]
10/18 4:26P
Johnson & Johnson, FDA Warn Of More Counterfeit Procrit
WASHINGTON (Dow Jones)--Johnson & Johnson's (JNJ) Ortho Biotech Products
unit and the Food and Drug Administration warned physicians that they have
found more counterfeit Procrit (epoetin alfa), a drug used to treat
chemotherapy-related anemia...
Dated Oct. 11, the letter said an additional counterfeit 40,000 units per
milliliter vials of Procrit were found, and displayed the lot number P004582...
Analysis of the counterfeit product showed it contained an active ingredient
and the container appeared intact, so it's likely the counterfeiters acquired
Procrit at a lower dose and relabeled the vials, the letter said.
[?]